Latest News and Press Releases

Oslo, Norway, 9 May 2018: Photocure ASA (OSE: PHO), held its annual general meeting on 9 May 2018 at 17:00 hours (CET). All proposals were resolved as presented in the notice convening the annual...

Reference is made to the stock exchange release on 7 May 2018 announcing a repurchase of 13,000 own shares. Photocure ASA purchased today, 8 May 2018, 13,000 own shares. The shares were purchased at...

The board of directors of Photocure ASA resolved today a share capital increase as part of the employee long-term incentive program for restricted shares in the company. In addition, the board of...

Oslo, 16 April 2018: Photocure ASA (OSE: PHO), has published the annual accounts and annual report for the financial year 2017. The annual accounts and annual report for the financial year 2017 are...

Oslo, 16 April 2018: Photocure ASA (OSE: PHO), calls for the annual general meeting of PHO to be held at Hoffsveien 4, 1st floor, 0275 Oslo, Norway on 9 May 2018 at 17:00 hours (CET). The...

Oslo, Norway, 27 February 2018: Photocure ASA (OSE:PHO), today reported a revenue growth of 27% for the important U.S. market in the fourth quarter of 2017, contributing to Hexvix®/Cysview®...

Photocure will present its fourth quarter and full year 2017 report on Tuesday 27 February 2018 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives...

Oslo, Norway, February 16, 2018 Photocure ASA (OSE: PHO), announced today that the U.S. Food and Drug Administration (FDA) approved its supplemental new drug application (sNDA) to extend the...

Oslo, Norway, December 13, 2017 - Photocure ASA (OSE: PHO) announces today that the company will present at the DNB Nordic Healthcare Conference on 14th of December 2017 in Oslo, Norway. Presenter...

Oslo, Norway, December 8, 2017: Photocure ASA (Photocure, PHO: OSE), today announced that the official Journal of the American Urologic Association (AUA), the Journal of Urology, published the...